Skip to main content
Earnings Labs
Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc. (TVTX)

NASDAQ·Healthcare·Biotechnology

$50.55

+1.15%

Mkt Cap $4.72B

Analyst Ratings

Buy

24

Hold

0

Sell

0

Price Target (24 analysts)

$70.60

Range $49.00 – $89.00

Implied Upside

+39.7%

Consensus $70.60 vs current $50.55